Structured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereof

US11327931B2 · kind B2 · utility

Assignee

• Roche Diabetes Care, Inc. · US

Inventors

• P. Douglas Walling · Indianapolis, US
• Juergen Rasch-Menges · Schwetzingen, DE
• Stefan Weinert · Pendleton, US
• Steven Bousamra · Carmel, US
• Abhishek S. Soni · San Jose, US
• Christoph Eisenhardt · Mannheim, DE

Key dates

• Filing date: Jan 7, 2020
• Grant date: May 10, 2022
• Expiry date: Apr 20, 2040

Classification

• Technology area (CPC G): Physics
• CPC primary: G16H40/67
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

A structured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereof are disclosed which implement a structured collection procedure based on a medical use case and/or question which provides at least one or more parameters defining entry criterion, a schedule of events, adherence criterion, and exit criterion. The entry criterion establish conditions needed to be met prior to obtaining biomarker data from the patient. Each event can include one or more of a performance time, patient guidance to perform the event, a request for information from the patient a request for patient action, and a request for collection of biomarker data from the patient. The adherence criterion can be used to assess whether an event performed is acceptable to addressing the medical use case and/or question, and the exit criterion establishes conditions needed to be met prior to exiting the collection procedure.